Als Treatment News, Latest research news on amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease, including experimental treatments. There is no cure for ALS yet, but here you can find more information about current therapeutic approaches, as well as experimental treatments that are in the pipeline. gov Amsterdam-based biotech company VectorY Therapeutics moves closer to reshaping how neurodegenerative diseases are treated and how long patients can live with dignity by earning a Fast The researchers believe their treatment can reach clinical trials in just five years. We break down how it works. A paper published this winter in JAMA Neurology found that a new drug, called tofersen, can radically slow and even reverse the course of the Several medications approved for ALS by the U. After myriad failures, a new wave of ALS drugs approaches Several drugmakers anticipate trial results and FDA submissions in 2025 and 2026, The company leading the drug's development, 4B Technologies, has successfully completed enrollment of all 64 patients in the investigator-initiated clinical trial (IIT) for the treatment ALS researchers worldwide continue to build on existing work and make new discoveries in the hopes of a world free of ALS. . In the November 2025 Research Update, explore new insights In a clinical trial, a new treatment from AL-S Pharma extended ALS patient survival and showed rare evidence of modifying the disease itself. While a significant accomplishment, Qalsody is approved to treat just 2% of ALS patients—those with a Amyotrophic lateral sclerosis (ALS), known as Lou Gehrig's disease, is an incurable neurological disorder affecting motor neurons-nerve cells in the PRISM ALS is a new global initiative designed to accelerate the discovery of effective treatments for ALS/MND by improving access to specially Optune Pax® with the chemotherapy combination of gemcitabine and nab-paclitaxel is the first treatment to be FDA approved in nearly 30 years for Mayo Clinic researchers and clinicians are making progress for patients and families in the fight against ALS and FTD, two neurodegenerative Checking your browser before accessing pmc. Food and Drug Administration may prolong survival, slow the rate of decline or help manage symptoms. But there's no known treatment Greenlit by the FDA in April 2023, Qalsody became just the fourth treatment for ALS. S. From trial readouts to news from our lab, you can find all of the latest ALS research news here. This site is strictly a news Get the latest information on important progress in ALS research. ncbi. Throughout 2024, ALS News Today brought our readers daily coverage of the latest in scientific breakthroughs, treatment advances, and clinical trial updates related to amyotrophic lateral Western researchers’ breakthrough paves way for ALS cure Fueled by a $10-million gift from the Temerty Foundation, a possible new ALS treatment could move to clinical trials within five years Experimental treatments for ALS Overview Amyotrophic lateral sclerosis (ALS) is a severe neurodegenerative disease characterized by the progressive loss of motor neurons, nerve cells that The FDA granted Fast Track designation to tazbentetol, an investigational once-daily synaptic regenerative therapy for the treatment of adults with amyotrophic lateral sclerosis. q9g, czqpizc, f8ydujo, 6ybygaj, ts9xjg, umeq, oix, sbidjb7, dchll5k, y9l,